United Health Products (UEEC) Debt to Equity (2016 - 2024)
United Health Products (UEEC) has disclosed Debt to Equity for 14 consecutive years, with -$0.1 as the latest value for Q3 2024.
- On a quarterly basis, Debt to Equity rose 14.43% to -$0.1 in Q3 2024 year-over-year; TTM through Sep 2024 was -$0.1, a 14.43% increase, with the full-year FY2023 number at -$0.12, down 6148.77% from a year prior.
- Debt to Equity was -$0.1 for Q3 2024 at United Health Products, up from -$0.1 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.0 in Q4 2022 to a low of -$0.29 in Q3 2022.
- A 5-year average of -$0.12 and a median of -$0.11 in 2023 define the central range for Debt to Equity.
- Biggest YoY gain for Debt to Equity was 99.15% in 2023; the steepest drop was 6148.77% in 2023.
- United Health Products' Debt to Equity stood at -$0.26 in 2020, then soared by 98.93% to -$0.0 in 2021, then skyrocketed by 31.03% to -$0.0 in 2022, then tumbled by 6148.77% to -$0.12 in 2023, then grew by 18.81% to -$0.1 in 2024.
- Per Business Quant, the three most recent readings for UEEC's Debt to Equity are -$0.1 (Q3 2024), -$0.1 (Q2 2024), and -$0.12 (Q1 2024).